Back

Volume 34 , Issue 4
July/August 2014
Pages 551–557

Maxillary Anterior Ridge Augmentation with Recombinant Human Bone Morphogenetic Protein 2

Ryan K. Edmunds, DDS, MS/Brian L. Mealey, DDS, MS/Michael P. Mills, DDS, MS/Daniel S. Thoma, DMD/John Schoolfield, MS/David L. Cochran, DDS, PhD/Jim Mellonig, DDS, MS

PMID: 25006772
DOI: 10.11607/prd.1737

No human studies exist on the use of recombinant human bone morphogenetic protein 2 (rhBMP-2) on an absorbable collagen sponge (ACS) as a sole graft material for lateral ridge augmentation in large ridge defect sites. This series evaluates the treatment outcome of maxillary anterior lateral ridge augmentation with rhBMP-2/ACS. Twenty patients were treated with rhBMP-2/ACS and fixation screws for space maintenance. Cone beam volumetric tomography measurements were used to determine gain in ridge width, and a bone core biopsy was obtained. The mean horizontal ridge gain was 1.2 mm across sites, and every site gained width. (Int J Periodontics Restorative Dent 2014;34:551–557. doi: 10.11607/prd.1737)

Full Text PDF File | Order Article

 

 

Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.